Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd. (Glenmark), incorporated in 1977, is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with seven molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies with thirteen manufacturing facilities in four countries and has five Research & Development (R&D) centers.

Read More
brick work finance academy